High ADHD comorbidity rates offer opportunity for pipeline products to capture market: GlobalData
Express Pharma
MARCH 4, 2024
Attention-deficit/hyperactivity disorder (ADHD) is a clinically heterogenous neurodevelopmental disorder with high rates of comorbidity with other childhood-onset psychiatric disorders as well as learning disorders. per cent for pediatric and adult ADHD patients, respectively. per cent and 28.3 per cent and 28.3
111 
Let's personalize your content